|
1
|
Goss PE and Chambers AF: Does tumour
dormancy offer a therapeutic target? Nat Rev Cancer. 10:871–877.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Páez D, Labonte MJ, Bohanes P, Zhang W,
Benhanim L, Ning Y, Wakatsuki T, Loupakis F and Lenz HJ: Cancer
dormancy: A model of early dissemination and late cancerrecurrence.
Clin Cancer Res. 18:645–653. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zappalà G, McDonald PG and Cole SW: Tumor
dormancy and the neuroendocrine system: An undisclosed connection?
Cancer Metastasis Rev. 32:189–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Alizadeh AM, Shiri S and Farsinejad S:
Metastasis review: From bench to bedside. Tumour Biol.
35:8483–8523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou YH, Liao SJ, Li D, Luo J, Wei JJ, Yan
B, Sun R, Shu Y, Wang Q, Zhang GM and Feng ZH: TLR4
ligand/H2O2 enhances TGF-β1 signaling to
induce metastatic potential of non-invasive breast cancer cells by
activating non-Smad pathways. PLoS One. 8:e659062013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barkan D, Kleinman H, Simmons JL, Asmussen
H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett
S, et al: Inhibition of metastatic outgrowth from single dormant
tumor cells by targeting the cytoskeleton. Cancer Res.
68:6241–6250. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warburton D and Bellusci S: The molecular
genetics of lung morphogenesis and injury repair. Paediatr Respir
Rev. 5 Suppl A:S283–S287. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fehrenbach H: Alveolar epithelial type II
cell: Defender of the alveolus revisited. Respir Res. 2:33–46.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu W, Xu B, Zhao Y, Yang N, Liu C, Wen G
and Zhang B: Wnt5a reverses the inhibitory effect of hyperoxia on
transdifferentiation of alveolar epithelial type II cells to type I
cells. J Physiol Biochem. 71:823–838. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barkauskas CE, Cronce MJ, Rackley CR,
Bowie EJ, Keene DR, Stripp BR, Randell SH, Noble PW and Hogan BL:
Type 2 alveolar cells are stem cells in adult lung. J Clin Invest.
123:3025–3036. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Yee M and O'Reilly MA:
Transdifferentiation of alveolar epithelial type II to type I cells
is controlled by opposing TGF-β and BMP signaling. Am J Physiol
Lung Cell Mol Physiol. 305:L409–L418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Catalano V, Turdo A, Di Franco S, Dieli F,
Todaro M and Stassi G: Tumor and its microenvironment: A
synergistic interplay. Semin Cancer Biol. 23:522–532. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liao SJ, Zhou YH, Yuan Y, Li D, Wu FH,
Wang Q, Zhu JH, Yan B, Wei JJ, Zhang GM and Feng ZH: Triggering of
Toll-like receptor 4 on metastatic breast cancer cells promotes
αvβ3-mediated adhesion and invasive migration. Breast Cancer Res
Treat. 133:853–863. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan YL, Zhou YH and Ye H: An improved
method for the isolation and primary culture of mouse AEC II.
Hainan Med J. 27:3280–3282. 2016.
|
|
17
|
Zhang L, Zhao S, Yuan L, Wu H, Jiang H and
Luo G: Hyperoxia-mediated LC3B activation contributes to the
impaired transdifferentiation of type II alveolar epithelial cells
(AECIIs) to type I cells (AECIs). Clin Exp Pharmacol Physiol.
43:834–843. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Isakson BE, Lubman RL, Seedorf GJ and
Boitano S: Modulation of pulmonary alveolar type II cell phenotype
and communication by extracellular matrix and KGF. Am J Physiol
Cell Physiol. 281:C1291–C1299. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Almog N: Molecular mechanisms underlying
tumor dormancy. Cancer Lett. 294:139–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Goss P, Allan AL, Rodenhiser DI, Foster PJ
and Chambers AF: New clinical and experimental approaches for
studying tumor dormancy: Does tumor dormancy offer a therapeutic
target? APMIS. 116:552–568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Weidenfeld K, Schif-Zuck S, Abu-Tayeh H,
Kang K, Kessler O, Weissmann M, Neufeld G and Barkan D: Dormant
tumor cells expressing LOXL2 acquire a stem-like phenotype
mediating their transition to proliferative growth. Oncotarget.
7:71362–71377. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang B, Zhao J, Li H, He KL, Chen Y, Chen
SH, Mayer L, Unkeless JC and Xiong H: Toll-like receptors on tumor
cells facilitate evasion of immune surveillance. Cancer Res.
65:5009–5014. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang EL, Qian ZR, Nakasono M, Tanahashi T,
Yoshimoto K, Bando Y, Kudo E, Shimada M and Sano T: High expression
of Toll-like receptor 4/myeloid differentiation factor 88 signals
correlates with poor prognosis in colorectal cancer. Br J Cancer.
102:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shih JY and Yang PC: The EMT regulator
SNAI2 and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Casimiro MC, Velasco-Velázquez M,
Aguirre-Alvarado C and Pestell RG: Overview of cyclins D1 function
in cancer and the CDK inhibitor landscape: Past and present. Expert
Opin Investig Drugs. 23:295–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao H, Chakraborty G, Lee-Lim AP, Mo Q,
Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH and Giancotti FG:
The BMP inhibitor Coco reactivates breast cancer cells at lung
metastatic sites. Cell. 150:764–779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Glick AB and Yuspa SH: Tissue homeostasis
and the control of the neoplastic phenotype in epithelial cancers.
Semin Cancer Biol. 15:75–83. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Friberg S and Nyström A: Cancer
metastases: Early dissemination and late recurrences. Cancer Growth
Metastasis. 8:43–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhaskaran M, Kolliputi N, Wang Y, Gou D,
Chintagari NR and Liu L: Trans-differentiation of alveolar
epithelial type II cells to type I cells involves autocrine
signaling by transforming growth factor beta 1 through the Smad
pathway. J Biol Chem. 282:3968–3976. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pidgeon GP, Harmey JH, Kay E, Da Costa M,
Redmond HP and Bouchier-Hayes DJ: The role of
endotoxin/lipopolysaccharide in surgically induced tumour growth in
a murine model of metastatic disease. Br J Cancer. 81:1311–1317.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsan MF and Gao B: Endogenous ligands of
Toll-like receptors. J Leukoc Biol. 76:514–519. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu
Y, Xie M, Yin X, Livesey KM, Loze MT, et al: DAMP-mediated
autophagy contributes to drug resistance. Autophagy. 7:112–114.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll
P and Anastassiou D: A multi-cancer mesenchymal transition gene
expression signature is associated with prolonged time to
recurrence in glioblastoma. PLoS One. 7:e347052012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hasan M, Sharma R and Saraya A: Slug is a
predictor of poor prognosis in esophageal squamous cell carcinoma
patients. PLoS One. 8:e828462013. View Article : Google Scholar : PubMed/NCBI
|
